DMAC - DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q2 2020 Results - Earnings Call Transcript
DiaMedica Therapeutics Inc. (DMAC)
Q2 2020 Earnings Conference Call
August 12, 2020 08:00 AM ET
Company Participants
Rick Pauls - President, Chief Executive Officer
Scott Kellen - Chief Financial Officer
Harry Alcorn - Chief Medical Officer
Conference Call Participants
Alexander Nowak - Craig-Hallum Capital Group
Thomas Flaten - Lake Street Capital Markets
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Second Quarter 2020 Financial Results Conference Call. An audio recording of the webcast will be available shortly after the call today on DiaMedica's website at www.diamedica.com in the Investors section.